Turkish pharmaceutical company ‘Türk İlaç ve Serum Sanayi A.Ş.’ (TRILC) has signed an export contract worth $4.994 million with the Ministry of Health and Medical Industry of Turkmenistan, according to a report published on 26 December on the KAP platform, as reported by the online publication ‘Business Turkmenistan’.

The Agreement provides for the supply of medicines and serums, with deliveries and payments to be completed by February 2026. The order has already been officially received, and production and logistics will be carried out according to schedule.

TRILC, based in Ankara, manufactures a wide range of medicines and is also involved in the import, marketing and representation of pharmaceutical, veterinary and cosmetic products.